The first COVID-19 vaccine to reach clinical trials in humans was determined to be both safe and generate an immune response against the virus — a “milestone” in the battle to defeat the deadly bug, a new study found. A single dose of the vaccine was found to produce virus-fighting antibodies and T cells, a…